<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Globalization and Health Reading by </title>
      <link>https://padlet.com/nicholas_huang1/globalizationandhealth</link>
      <description>Nayeon, Stephanie, Cole</description>
      <language>en-us</language>
      <pubDate>2023-12-01 22:41:16 UTC</pubDate>
      <lastBuildDate>2023-12-04 12:04:34 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url>https://padlet.net/icons/png/1f30e.png</url>
      </image>
      <item>
         <title>1. Explain how poverty contributes to an elevated risk of mental illness, and how inadequate access to care further compounds this challenge.</title>
         <author>864leena</author>
         <link>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811007657</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-12-01 22:47:42 UTC</pubDate>
         <guid>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811007657</guid>
      </item>
      <item>
         <title>2. Can you briefly explain the core idea behind the community-based approach in mental health programs?</title>
         <author>864leena</author>
         <link>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811007789</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-12-01 22:48:02 UTC</pubDate>
         <guid>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811007789</guid>
      </item>
      <item>
         <title>3. What do you think the “challenges of mental health” in this paper have to do with globalization?</title>
         <author>864leena</author>
         <link>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811007863</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-12-01 22:48:14 UTC</pubDate>
         <guid>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811007863</guid>
      </item>
      <item>
         <title>1. What is the DALY scale? What are its constituent measures?</title>
         <author>nicholas_huang1</author>
         <link>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811310460</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-12-02 14:45:18 UTC</pubDate>
         <guid>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811310460</guid>
      </item>
      <item>
         <title>2. What are three important problems with the DALY? </title>
         <author>nicholas_huang1</author>
         <link>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811310629</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-12-02 14:45:38 UTC</pubDate>
         <guid>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811310629</guid>
      </item>
      <item>
         <title>3. Why might the DALY scale prove ineffective or biased in global health? What aspects are based on cultural/social, rather than biomedical, measures?</title>
         <author>nicholas_huang1</author>
         <link>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811310983</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-12-02 14:46:24 UTC</pubDate>
         <guid>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811310983</guid>
      </item>
      <item>
         <title>1. Why did WHO recommend the use of DOTS in treating TB and how was its efficacy on MDRTB?</title>
         <author></author>
         <link>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811405924</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-12-02 18:24:41 UTC</pubDate>
         <guid>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811405924</guid>
      </item>
      <item>
         <title>3. What are the challenges of widespread use of an intervention by global health authorities?</title>
         <author></author>
         <link>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811411121</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-12-02 18:38:59 UTC</pubDate>
         <guid>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811411121</guid>
      </item>
      <item>
         <title>2. How was MDRTB initially handled in Peru and why did Global health authorities not recommend treating MDRTB with an effective regimen in resource poor settings?</title>
         <author></author>
         <link>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811416489</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-12-02 18:52:42 UTC</pubDate>
         <guid>https://padlet.com/nicholas_huang1/globalizationandhealth/wish/2811416489</guid>
      </item>
   </channel>
</rss>
